| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.02 |